Compare NVX & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVX | OPRX |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | Australia | United States |
| Employees | 192 | N/A |
| Industry | Industrial Machinery/Components | Business Services |
| Sector | Miscellaneous | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.9M | 96.1M |
| IPO Year | N/A | 2008 |
| Metric | NVX | OPRX |
|---|---|---|
| Price | $0.44 | $6.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 419.1K | ★ 461.7K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | $3,904.19 | $3.88 |
| Revenue Next Year | $91.72 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $0.42 | $4.54 |
| 52 Week High | $3.86 | $22.25 |
| Indicator | NVX | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.03 | 66.62 |
| Support Level | N/A | $5.80 |
| Resistance Level | $0.74 | $7.10 |
| Average True Range (ATR) | 0.04 | 0.33 |
| MACD | -0.01 | 0.17 |
| Stochastic Oscillator | 8.31 | 84.18 |
NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.